Stool samples were collected in a cross-sectional study of patients (N = 42, 29 female, aged 46.7, +- 11.3) with persistent neurological symptoms following a COVID-19 infection to investigate associat
We performed longitudinal plasma proteomics analysis and determined absolute protein levels in a Canadian cohort (n=74) at admission day to hospital for acute COVID-19 and at 3 and 6 months after diag